With the analysis among 3,836 patents, we discovered top 416 key players by total patent application. Institut National de la Santé et de la Recherche Médicale, Immatics Biotechnologies GmbH, Novartis AG are dominant in this area. They take 5.42% of the total patent filing.
Institut National de la Santé et de la Recherche Médicale
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 69
Basel-Stadt, Switzerland
Patent: 66
Molecular Templates, Inc.
Texas, United States
Patent: 60
California, United States
Patent: 58
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 56
Utrecht, Netherlands
Patent: 51
Assistance Publique des Hôpitaux de Paris SA
With the analysis among 354 patents, we discovered top 31 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Hrain Biotechnology Co. Ltd., Emergex Vaccines Holding Ltd. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Hrain Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 43
Emergex Vaccines Holding Ltd.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 12
Asher Biotherapeutics, Inc.
California, United States
Patent: 11
Hovedstaden, Denmark
Patent: 10
California, United States
Patent: 9
North Carolina, United States
Patent: 5
Orionis Biosciences, Inc.
Massachusetts, United States
Patent: 5
With the analysis among related 2,470 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Institut National de la Santé et de la Recherche Médicale, Immatics Biotechnologies GmbH, Emergex Vaccines Holding Ltd. take 5.87% of patent filing during this period.
Institut National de la Santé et de la Recherche Médicale
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 48
Emergex Vaccines Holding Ltd.
California, United States
Patent: 40
Centre National De La Recherche Scientif
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 33
Molecular Templates, Inc.
Texas, United States
Patent: 31
Washington, United States
Patent: 29
Regents of the University of California
California, United States
Patent: 27
With the analysis among related 2,470 patents in last 5 years, we discover 319 new entrants. Emergex Vaccines Holding Ltd., Immatics US, Inc., Alkermes Pharma Ireland Ltd. are the most active new entrants in this area.
Emergex Vaccines Holding Ltd.
Texas, United States
Patent: 26
Alkermes Pharma Ireland Ltd.
California, United States
Patent: 17
Rheinland-Pfalz, Germany
Patent: 17
Fusion Pharmaceuticals, Inc.
Ontario, Canada
Patent: 15
Elixiron Immunotherapeutics (Hong Kong) Limited
undefined undefined
Patent: 14
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 14
Ruiwei (Shenzhen) Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 14
With the analysis among 2,471 patents, we discovered top 232 universities and scientific research institutions by total patent application. The Johns Hopkins University, Kyoto University, The Trustees of Columbia University in The City of New York are dominant in this area. They take 13.35% of the total patent filing.
The Johns Hopkins University
Kyoto-fu, Japan
Patent: 54
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 47
Tokyo-to, Japan
Patent: 40
Charité - Universitätsmedizin Berlin
Berlin, Germany
Patent: 39
Connecticut, United States
Patent: 33
Ludwig-Maximilians-Universität München
Bayern, Germany
Patent: 32
Tokyo-to, Japan
Patent: 29
Okayama-ken, Japan
Patent: 25